148.43 USD
+1.21 (+0.82%)
148.43 USD
0 (0%)
ICUI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. ICUI has an average financial health and profitability rating. ICUI has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year ICUI was profitable.
ICUI had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: ICUI reported negative net income in multiple years.
Of the past 5 years ICUI 4 years had a positive operating cash flow.
1.2 Ratios
With a decent Return On Assets value of -0.18%, ICUI is doing good in the industry, outperforming 72.73% of the companies in the same industry.
ICUI has a Return On Equity of -0.35%. This is in the better half of the industry: ICUI outperforms 73.26% of its industry peers.
The Return On Invested Capital of ICUI (2.86%) is better than 70.59% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ICUI is significantly below the industry average of 8.80%.
The 3 year average ROIC (1.36%) for ICUI is below the current ROIC(2.86%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROIC | 2.86% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
1.3 Margins
ICUI's Operating Margin of 5.63% is fine compared to the rest of the industry. ICUI outperforms 71.12% of its industry peers.
ICUI's Operating Margin has declined in the last couple of years.
The Gross Margin of ICUI (36.47%) is worse than 71.12% of its industry peers.
ICUI's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% |
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ICUI is destroying value.
ICUI has more shares outstanding than it did 1 year ago.
ICUI has more shares outstanding than it did 5 years ago.
ICUI has a worse debt/assets ratio than last year.
2.2 Solvency
ICUI has an Altman-Z score of 2.22. This is not the best score and indicates that ICUI is in the grey zone with still only limited risk for bankruptcy at the moment.
ICUI has a Altman-Z score of 2.22. This is in the better half of the industry: ICUI outperforms 63.64% of its industry peers.
The Debt to FCF ratio of ICUI is 21.21, which is on the high side as it means it would take ICUI, 21.21 years of fcf income to pay off all of its debts.
ICUI has a Debt to FCF ratio of 21.21. This is in the better half of the industry: ICUI outperforms 70.05% of its industry peers.
ICUI has a Debt/Equity ratio of 0.62. This is a neutral value indicating ICUI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.62, ICUI is doing worse than 62.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Altman-Z | 2.22 |
ROIC/WACC0.38
WACC7.6%
2.3 Liquidity
ICUI has a Current Ratio of 2.45. This indicates that ICUI is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ICUI (2.45) is comparable to the rest of the industry.
ICUI has a Quick Ratio of 1.19. This is a normal value and indicates that ICUI is financially healthy and should not expect problems in meeting its short term obligations.
ICUI has a worse Quick ratio (1.19) than 68.45% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
ICUI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.14%, which is quite impressive.
ICUI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.28% yearly.
Looking at the last year, ICUI shows a decrease in Revenue. The Revenue has decreased by -0.84% in the last year.
Measured over the past years, ICUI shows a quite strong growth in Revenue. The Revenue has been growing by 13.47% on average per year.
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
3.2 Future
ICUI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.56% yearly.
Based on estimates for the next years, ICUI will show a small growth in Revenue. The Revenue will grow by 2.95% on average per year.
EPS Next Y23.92%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue Next Year-4.6%
Revenue Next 2Y-3.09%
Revenue Next 3Y-0.65%
Revenue Next 5Y2.95%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 18.65, the valuation of ICUI can be described as rather expensive.
82.89% of the companies in the same industry are more expensive than ICUI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.54, ICUI is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 18.10, the valuation of ICUI can be described as rather expensive.
83.42% of the companies in the same industry are more expensive than ICUI, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ICUI to the average of the S&P500 Index (23.78), we can say ICUI is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.65 | ||
| Fwd PE | 18.1 |
4.2 Price Multiples
83.96% of the companies in the same industry are more expensive than ICUI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ICUI is valued a bit cheaper than 73.26% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 58.88 | ||
| EV/EBITDA | 13.95 |
4.3 Compensation for Growth
ICUI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ICUI's earnings are expected to grow with 14.98% in the coming years.
PEG (NY)0.78
PEG (5Y)N/A
EPS Next 2Y14.84%
EPS Next 3Y14.98%
5. Dividend
5.1 Amount
No dividends for ICUI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
148.43
+1.21 (+0.82%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners117.94%
Inst Owner Change3.93%
Ins Owners0.96%
Ins Owner Change-1.93%
Market Cap3.66B
Revenue(TTM)2.32B
Net Income(TTM)-7.36M
Analysts83.33
Price Target185.03 (24.66%)
Short Float %5.5%
Short Ratio4.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.05%
Min EPS beat(2)37.25%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)36.86%
Min EPS beat(4)31.74%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)33.65%
EPS beat(12)12
Avg EPS beat(12)26.3%
EPS beat(16)15
Avg EPS beat(16)20.15%
Revenue beat(2)1
Avg Revenue beat(2)0.69%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)3.14%
Revenue beat(4)3
Avg Revenue beat(4)1.65%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.14%
Revenue beat(8)6
Avg Revenue beat(8)1.04%
Revenue beat(12)6
Avg Revenue beat(12)-0.86%
Revenue beat(16)8
Avg Revenue beat(16)-0.49%
PT rev (1m)4.13%
PT rev (3m)2.95%
EPS NQ rev (1m)-0.69%
EPS NQ rev (3m)-0.97%
EPS NY rev (1m)8.13%
EPS NY rev (3m)8.13%
Revenue NQ rev (1m)0.65%
Revenue NQ rev (3m)0.27%
Revenue NY rev (1m)0.98%
Revenue NY rev (3m)0.98%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 18.65 | ||
| Fwd PE | 18.1 | ||
| P/S | 1.58 | ||
| P/FCF | 58.88 | ||
| P/OCF | 22.99 | ||
| P/B | 1.72 | ||
| P/tB | N/A | ||
| EV/EBITDA | 13.95 |
EPS(TTM)7.96
EY5.36%
EPS(NY)8.2
Fwd EY5.53%
FCF(TTM)2.52
FCFY1.7%
OCF(TTM)6.46
OCFY4.35%
SpS93.98
BVpS86.16
TBVpS-1.47
PEG (NY)0.78
PEG (5Y)N/A
Graham Number124.22
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -0.18% | ||
| ROE | -0.35% | ||
| ROCE | 3.62% | ||
| ROIC | 2.86% | ||
| ROICexc | 3.12% | ||
| ROICexgc | 9.01% | ||
| OM | 5.63% | ||
| PM (TTM) | N/A | ||
| GM | 36.47% | ||
| FCFM | 2.68% |
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.62 | ||
| Debt/FCF | 21.21 | ||
| Debt/EBITDA | 3.95 | ||
| Cap/Depr | 47.91% | ||
| Cap/Sales | 4.19% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 47.79% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.45 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 2.22 |
F-Score7
WACC7.6%
ROIC/WACC0.38
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
EPS Next Y23.92%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-8.85%
Revenue Next Year-4.6%
Revenue Next 2Y-3.09%
Revenue Next 3Y-0.65%
Revenue Next 5Y2.95%
EBIT growth 1Y142.55%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year43.36%
EBIT Next 3Y18.75%
EBIT Next 5Y17.88%
FCF growth 1Y597.89%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y117.81%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%
ICU MEDICAL INC / ICUI FAQ
What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a fundamental rating of 4 / 10 to ICUI.
What is the valuation status of ICU MEDICAL INC (ICUI) stock?
ChartMill assigns a valuation rating of 6 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.
How profitable is ICU MEDICAL INC (ICUI) stock?
ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.
What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?
The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 23.92% in the next year.